Update in the approach to and management of heart failure

Keyphrases

• Heart Failure 100%
• Heart Failure Management 100%
• Angiotensin-converting Enzyme Inhibitor (ACEi) 75%
• Disease Progression 25%
• Chronic Disease 25%
• Direct Therapy 25%
• Beta-blockers 25%
• Clinical Diagnosis 25%
• Patient Experience 25%
• Functional Status 25%
• Intolerant 25%
• Newly Diagnosed 25%
• Second-line Agents 25%
• Left Ventricular Dysfunction 25%
• Angiotensin Receptor Blockers 25%
• Progress Management 25%
• Digoxin 25%
• Hemodynamic Status 25%
• Optimal Medical Therapy 25%
• Aggressive Management 25%
• Severe Hyperkalemia 25%
• Brain Natriuretic Peptide 25%
• Heart Failure Stages 25%
• Patients with Chronic Heart Failure 25%
• Initial Workup 25%
• Close Monitoring 25%
• Aldosterone Antagonists 25%
• Comorbid Conditions 25%
• Mortality Benefit 25%

Nursing and Health Professions

• Congestive Heart Failure 100%
• Dipeptidyl Carboxypeptidase Inhibitor 37%
• Disease Exacerbation 12%
• Chronic Disease 12%
• Functional Status 12%
• Physical Examination 12%
• Beta Adrenergic Receptor Blocking Agent 12%
• Brain Natriuretic Peptide 12%
• Aldosterone Antagonist 12%
• Digoxin 12%
• Heart Left Ventricle Failure 12%
• Hyperkalemia 12%
• Angiotensin Receptor Antagonist 12%
• Patient Experience 12%
• Hemodynamic 12%

Medicine and Dentistry

• Congestive Heart Failure 100%
• ACE Inhibitor 37%
• Chronic Disease 12%
• Disease Exacerbation 12%
• Hemodynamic 12%
• Brain Natriuretic Peptide 12%
• Hyperkalemia 12%
• Physical Examination 12%
• Functional Status 12%
• Beta Adrenergic Receptor Blocking Agent 12%
• Heart Left Ventricle Failure 12%
• Patient Experience 12%
• Angiotensin Receptor Antagonist 12%
• Digoxin 12%
• Aldosterone Antagonist 12%